Literature DB >> 8369688

Fluoxetine-warfarin interaction.

S Woolfrey1, N S Gammack, M S Dewar, P J Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8369688      PMCID: PMC1678114          DOI: 10.1136/bmj.307.6898.241-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  1 in total

1.  Potential interaction between warfarin sodium and fluoxetine.

Authors:  R J Claire; M E Servis; D L Cram
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

  1 in total
  10 in total

Review 1.  Clinically significant drug interactions with newer antidepressants.

Authors:  Edoardo Spina; Gianluca Trifirò; Filippo Caraci
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

2.  Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.

Authors:  Martina Teichert; Loes E Visser; Andrė G Uitterlinden; Albert Hofman; Peter J Buhre; Sabine Straus; Peter A G M De Smet; Bruno H Stricker
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

Review 3.  Drug interactions of clinical significance with selective serotonin reuptake inhibitors.

Authors:  P B Mitchell
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

4.  Emotional Blunting, Cognitive Impairment, Bone Fractures, and Bleeding as Possible Side Effects of Long-Term Use of SSRIs.

Authors:  Donatella Marazziti; Federico Mucci; Beniamino Tripodi; Manuel Glauco Carbone; Alessia Muscarella; Valentina Falaschi; Stefano Baroni
Journal:  Clin Neuropsychiatry       Date:  2019-04

Review 5.  Drug Interactions Affecting Oral Anticoagulant Use.

Authors:  Philip L Mar; Rakesh Gopinathannair; Brooke E Gengler; Mina K Chung; Arturo Perez; Jonathan Dukes; Michael D Ezekowitz; Dhanunjaya Lakkireddy; Gregory Y H Lip; Mike Miletello; Peter A Noseworthy; James Reiffel; James E Tisdale; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-05-27

Review 6.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

7.  Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions.

Authors:  Adrián LLerena; Pedro Dorado; Roland Berecz; Antonio P González; Eva M Peñas-LLedó
Journal:  Eur J Clin Pharmacol       Date:  2004-01-16       Impact factor: 2.953

8.  Warfarin and Antidepressants: Happiness without Hemorrhaging.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-07

9.  Describing the profile of patients on concurrent rifampin and warfarin therapy in western Kenya: a case series.

Authors:  M W Maina; S D Pastakia; I Manji; N Kirui; C Kirwa; Rakhi Karwa
Journal:  Drugs R D       Date:  2013-09

10.  Bupropion-warfarin combination: a serious complication.

Authors:  Amar D Bavle; Akshay S Phatak
Journal:  Indian J Psychol Med       Date:  2013-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.